Diabetes, Vol 46, Issue 9 1526-1531, Copyright © 1997 by American Diabetes Association

ARTICLES

Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice

J Ventre, T Doebber, M Wu, K MacNaul, K Stevens, M Pasparakis, G Kollias and DE Moller
Department of Molecular Endocrinology, Merck Research Laboratories, Rahway, New Jersey 07065, USA.

To address the hypothesis that tumor necrosis factor (TNF)-alpha has a role in obesity-associated insulin resistance or the regulation of in vivo lipid metabolism, mice with targeted disruption of the TNF-alpha gene were generated and studied. The absence of TNF-alpha protein in TNF-null (-/-) mice was confirmed. Lean or obese (gold-thioglucose [GTG]-injected) homozygous (-/-) mice were compared with lean or obese age- and sex-matched wild-type (+/+) mice derived from the same line at 13, 19, and 28 weeks of age. The following parameters were significantly affected in lean -/- versus +/+ mice: Body weight was not affected until week 28 (decreased by 14%); epididymal fat pad weight also decreased (25%) at this time, as did percentage body fat (16%), while percentage body protein was increased 13%. Fed plasma insulin levels decreased 47% (28 weeks), triglyceride levels decreased (all three ages; maximum 35% at 19 weeks), and fed plasma leptin decreased 33% (28 weeks). Fasting glucose was slightly (10%) reduced, but the glucose response to an oral glucose tolerance test (OGTT) was not affected. There was a trend (NS) toward increased total adipose tissue lipoprotein lipase in -/- versus +/+ mice. GTG-treatment resulted in obese -/- and +/+ mice with equal mean body weights (42 and 58% increased weight versus lean mice). The following parameters were significantly different in obese -/- mice: fasting plasma glucose decreased 13% (28 weeks), fed plasma insulin decreased 67% (28 weeks), and insulin response to OGTT was decreased by 50%. For both groups of obese mice, glucose levels during the OGTT were substantially increased compared with those in lean mice; however, mean stimulated glucose levels were 20% lower in obese -/- versus +/+ mice. We conclude 1) that TNF-alpha functions to regulate plasma triglycerides and body adiposity and 2) that although TNF-alpha contributes to reduced insulin sensitivity in older or obese mice, the absence of TNF-alpha is not sufficient to substantially protect against insulin resistance in the GTG hyperphagic model of rodent obesity.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. V. Ramana, R. Tammali, A. B. M. Reddy, A. Bhatnagar, and S. K. Srivastava Aldose Reductase-Regulated Tumor Necrosis Factor-{alpha} Production Is Essential for High Glucose-Induced Vascular Smooth Muscle Cell Growth Endocrinology, September 1, 2007; 148(9): 4371 - 4384. [Abstract] [Full Text] [PDF]

				B. M. De Taeye, T. Novitskaya, O. P. McGuinness, L. Gleaves, M. Medda, J. W. Covington, and D. E. Vaughan Macrophage TNF-{alpha} contributes to insulin resistance and hepatic steatosis in diet-induced obesity Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E713 - E725. [Abstract] [Full Text] [PDF]

				E. R. Ropelle, J. R. Pauli, P. O. Prada, C. T. de Souza, P. K. Picardi, M. C. Faria, D. E. Cintra, M. F. d. A. Fernandes, M. B. Flores, L. A. Velloso, et al. Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: the role of PTP1B and IRS-1 serine phosphorylation J. Physiol., December 15, 2006; 577(3): 997 - 1007. [Abstract] [Full Text] [PDF]

				E. Kamphuis, T. Junt, Z. Waibler, R. Forster, and U. Kalinke Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia Blood, November 15, 2006; 108(10): 3253 - 3261. [Abstract] [Full Text] [PDF]

				G. G. Gosman, H. I. Katcher, and R. S. Legro Obesity and the role of gut and adipose hormones in female reproduction Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601. [Abstract] [Full Text] [PDF]

				G. Tuncman, J. Hirosumi, G. Solinas, L. Chang, M. Karin, and G. S. Hotamisligil Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance PNAS, July 11, 2006; 103(28): 10741 - 10746. [Abstract] [Full Text] [PDF]

				N. M. Punjabi and V. Y. Polotsky Disorders of glucose metabolism in sleep apnea J Appl Physiol, November 1, 2005; 99(5): 1998 - 2007. [Abstract] [Full Text] [PDF]

				J.-a Kim, D. C. Yeh, M. Ver, Y. Li, A. Carranza, T. P. Conrads, T. D. Veenstra, M. A. Harrington, and M. J. Quon Phosphorylation of Ser24 in the Pleckstrin Homology Domain of Insulin Receptor Substrate-1 by Mouse Pelle-like Kinase/Interleukin-1 Receptor-associated Kinase: CROSS-TALK BETWEEN INFLAMMATORY SIGNALING AND INSULIN SIGNALING THAT MAY CONTRIBUTE TO INSULIN RESISTANCE J. Biol. Chem., June 17, 2005; 280(24): 23173 - 23183. [Abstract] [Full Text] [PDF]

				C. Shin, J. Kim, J. Kim, S. Lee, J. Shim, K. In, K. Kang, S. Yoo, N. Cho, K. Kimm, et al. Association of Habitual Snoring with Glucose and Insulin Metabolism in Nonobese Korean Adult Men Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 287 - 291. [Abstract] [Full Text] [PDF]

				B. E. Wisse The Inflammatory Syndrome: The Role of Adipose Tissue Cytokines in Metabolic Disorders Linked to Obesity J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2792 - 2800. [Abstract] [Full Text] [PDF]

				N. M. Punjabi, E. Shahar, S. Redline, D. J. Gottlieb, R. Givelber, and H. E. Resnick Sleep-Disordered Breathing, Glucose Intolerance, and Insulin Resistance: The Sleep Heart Health Study Am. J. Epidemiol., September 15, 2004; 160(6): 521 - 530. [Abstract] [Full Text] [PDF]

				G. L. Kelley, G. Allan, and S. Azhar High Dietary Fructose Induces a Hepatic Stress Response Resulting in Cholesterol and Lipid Dysregulation Endocrinology, February 1, 2004; 145(2): 548 - 555. [Abstract] [Full Text] [PDF]

				J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF]

				Z. Pausova, L. Sedova, J. Berube, P. Hamet, J. Tremblay, M. Dumont, D. Gaudet, M. Pravenec, V. Kren, and J. Kunes Segment of Rat Chromosome 20 Regulates Diet-Induced Augmentations in Adiposity, Glucose Intolerance, and Blood Pressure Hypertension, May 1, 2003; 41(5): 1047 - 1055. [Abstract] [Full Text] [PDF]

				M. Fujishiro, Y. Gotoh, H. Katagiri, H. Sakoda, T. Ogihara, M. Anai, Y. Onishi, H. Ono, M. Abe, N. Shojima, et al. Three Mitogen-Activated Protein Kinases Inhibit Insulin Signaling by Different Mechanisms in 3T3-L1 Adipocytes Mol. Endocrinol., March 1, 2003; 17(3): 487 - 497. [Abstract] [Full Text] [PDF]

				M. Freemark Pharmacologic Approaches to the Prevention of Type 2 Diabetes in High Risk Pediatric Patients J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 3 - 13. [Full Text] [PDF]

				J. J. Senn, P. J. Klover, I. A. Nowak, and R. A. Mooney Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes Diabetes, December 1, 2002; 51(12): 3391 - 3399. [Abstract] [Full Text] [PDF]

				H. Xu, K. T. Uysal, J. D. Becherer, P. Arner, and G. S. Hotamisligil Altered Tumor Necrosis Factor-{alpha} (TNF-{alpha}) Processing in Adipocytes and Increased Expression of Transmembrane TNF-{alpha} in Obesity Diabetes, June 1, 2002; 51(6): 1876 - 1883. [Abstract] [Full Text] [PDF]

				H. Xu, J. Hirosumi, K. T. Uysal, A. D. Guler, and G. S. Hotamisligil Exclusive Action of Transmembrane TNF{alpha} in Adipose Tissue Leads to Reduced Adipose Mass and Local But Not Systemic Insulin Resistance Endocrinology, April 1, 2002; 143(4): 1502 - 1511. [Abstract] [Full Text] [PDF]

				T. Wu, J. P. Dorn, R. P. Donahue, C. T. Sempos, and M. Trevisan Associations of Serum C-reactive Protein with Fasting Insulin, Glucose, and Glycosylated Hemoglobin : The Third National Health and Nutrition Examination Survey, 1988-1994 Am. J. Epidemiol., January 1, 2002; 155(1): 65 - 71. [Abstract] [Full Text] [PDF]

				J. I. Barzilay, L. Abraham, S. R. Heckbert, M. Cushman, L. H. Kuller, H. E. Resnick, and R. P. Tracy The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly: The Cardiovascular Health Study Diabetes, October 1, 2001; 50(10): 2384 - 2389. [Abstract] [Full Text]

				J. W. Tomlinson, J. Moore, M. S. Cooper, I. Bujalska, M. Shahmanesh, C. Burt, A. Strain, M. Hewison, and P. M. Stewart Regulation of Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue: Tissue-Specific Induction by Cytokines Endocrinology, May 1, 2001; 142(5): 1982 - 1989. [Abstract] [Full Text]

				A. INUI Transgenic study of energy homeostasis equation: implications and confounding influences FASEB J, November 1, 2000; 14(14): 2158 - 2170. [Abstract] [Full Text]

				E. Nisoli, L. Briscini, A. Giordano, C. Tonello, S. M. Wiesbrock, K. T. Uysal, S. Cinti, M. O. Carruba, and G. S. Hotamisligil Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity PNAS, July 5, 2000; 97(14): 8033 - 8038. [Abstract] [Full Text] [PDF]

				Z. Pausova, B. Deslauriers, D. Gaudet, J. Tremblay, T. A. Kotchen, P. Larochelle, A. W. Cowley, and P. Hamet Role of Tumor Necrosis Factor-{alpha} Gene Locus in Obesity and Obesity-Associated Hypertension in French Canadians Hypertension, July 1, 2000; 36(1): 14 - 19. [Abstract] [Full Text] [PDF]

				A. Inui Transgenic Approach to the Study of Body Weight Regulation Pharmacol. Rev., March 1, 2000; 52(1): 35 - 62. [Abstract] [Full Text] [PDF]

				H. Xu, J. K. Sethi, and G. S. Hotamisligil Transmembrane Tumor Necrosis Factor (TNF)-alpha Inhibits Adipocyte Differentiation by Selectively Activating TNF Receptor 1 J. Biol. Chem., September 10, 1999; 274(37): 26287 - 26295. [Abstract] [Full Text] [PDF]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				F. Samad, K. T. Uysal, S. M. Wiesbrock, M. Pandey, G. S. Hotamisligil, and D. J. Loskutoff Tumor necrosis factor alpha  is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1 PNAS, June 8, 1999; 96(12): 6902 - 6907. [Abstract] [Full Text] [PDF]

				P. E. Morange, M. C. Alessi, M. Verdier, D. Casanova, G. Magalon, and I. Juhan-Vague PAI-1 Produced Ex Vivo by Human Adipose Tissue Is Relevant to PAI-1 Blood Level Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1361 - 1365. [Abstract] [Full Text] [PDF]

				B. Zinman, A. J. G. Hanley, S. B. Harris, J. Kwan, and I. G. Fantus Circulating Tumor Necrosis Factor-{alpha} Concentrations in a Native Canadian Population with High Rates of Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 272 - 278. [Abstract] [Full Text]

				K. T. Uysal, S. M. Wiesbrock, and G. S. Hotamisligil Functional Analysis of Tumor Necrosis Factor (TNF) Receptors in TNF-{alpha}-Mediated Insulin Resistance in Genetic Obesity Endocrinology, December 1, 1998; 139(12): 4832 - 4838. [Abstract] [Full Text] [PDF]

				A. T. Cheung, D. Ree, J. K. Kolls, J. Fuselier, D. H. Coy, and M. Bryer-Ash An in Vivo Model for Elucidation of the Mechanism of Tumor Necrosis Factor-{alpha} (TNF-{alpha})-Induced Insulin Resistance: Evidence for Differential Regulation of Insulin Signaling by TNF-{alpha} Endocrinology, December 1, 1998; 139(12): 4928 - 4935. [Abstract] [Full Text] [PDF]

				C. L. Morin, E. C. Gayles, D. A. Podolin, Y. Wei, M. Xu, and M. J. Pagliassotti Adipose Tissue-Derived Tumor Necrosis Factor Activity Correlates with Fat Cell Size But Not Insulin Action in Aging Rats Endocrinology, December 1, 1998; 139(12): 4998 - 5005. [Abstract] [Full Text] [PDF]

				B. N. Finck, K. W. Kelley, R. Dantzer, and R. W. Johnson In Vivo and in Vitro Evidence for the Involvement of Tumor Necrosis Factor-{alpha} in the Induction of Leptin by Lipopolysaccharide Endocrinology, May 1, 1998; 139(5): 2278 - 2283. [Abstract] [Full Text] [PDF]

				M. Moldes, F. Lasnier, X. Gauthereau, C. Klein, J. Pairault, B. Feve, and A.-M. Chambaut-Guerin Tumor Necrosis Factor-alpha -induced Adipose-related Protein (TIARP), a Cell-surface Protein That Is Highly Induced by Tumor Necrosis Factor-alpha and Adipose Conversion J. Biol. Chem., August 31, 2001; 276(36): 33938 - 33946. [Abstract] [Full Text] [PDF]

				M. Ryden, A. Dicker, V. van Harmelen, H. Hauner, M. Brunnberg, L. Perbeck, F. Lonnqvist, and P. Arner Mapping of Early Signaling Events in Tumor Necrosis Factor-alpha -mediated Lipolysis in Human Fat Cells J. Biol. Chem., January 4, 2002; 277(2): 1085 - 1091. [Abstract] [Full Text] [PDF]